BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23408758)

  • 1. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
    Coppock JD; Willis BC; Stoler MH; Mills AM
    Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
    Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
    Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
    Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
    Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
    J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
    Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
    Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
    Jarboe EA; Thompson LC; Heinz D; McGregor JA; Shroyer KR
    Hum Pathol; 2004 Apr; 35(4):396-402. PubMed ID: 15116318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of human telomerase RNA gene amplification detection for cervical cancer screening.
    Chen SM; Lin W; Liu X; Zhang YZ
    Asian Pac J Cancer Prev; 2012; 13(5):2063-8. PubMed ID: 22901172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
    Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
    Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
    Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.